Next Wednesday: Rethinking What We Ask of Patients
|
Hi! In one week, T2B is bringing together several patient advocacy leaders for a candid conversation about what patients are asked to contribute—and the terms of those exchanges. Regardless of whether patient advocacy is formally in your remit, we communicators work with patients and caregivers regularly to share their experiences through corporate campaigns, employee events, advisory boards, focus groups, clinical development initiatives, and more. Our August Comm Convo will explore how we can help create clearer expectations, fairer compensation, meaningful influence, and stronger follow-through. We’ll hear from:
Together, they bring experience spanning patient advocacy organizations, corporate partnerships, communications, research, and biopharma. We’ll discuss how to recognize one-sided requests, build more thoughtful patient invitations, and work more deliberately with patient advocacy colleagues, including when communications should lead, support, or step back. Importantly, this conversation will also establish a shared foundation for upcoming programming from the T2B Patient Advocacy & Engagement Roundtable. RSVP: Rethinking What We Ask of Patients🗓️ Wednesday, August 26th Register to join us. Thanks and hope to see you there! Lynnea |
T2B Monthly
Hi! In our July Comm Convo -- led by BioPharma Dive reporter Gwen Wu -- our panelists, Chloe Kirk, Ph.D. (BiotechTV), Ben McLeod (Convey Bio + The Biotech Voyager), and Liz Puzio (Simtra BioPharma Solutions), discussed how we can help scientists and executives communicate with more credibility without over-managing what they say. Our top 10 takeaways from Why Only Some Platforms Are Trusted When Everyone Has One: 1. Separate the executive from the corporate microphone. Trust slips for leaders...
Hi! Regardless if patient advocacy is in your or your clients' remit, we communicators still work with patients and patient advocacy organizations all the time -- from storytelling and disease education to advisory boards, clinical trial communications, research initiatives, employee engagement, and beyond. But the role of patient advocacy has evolved, and so should the way we approach those relationships. Tomorrow’s Comm Convo will bring together leaders from the Cystic Fibrosis Foundation,...
Hi! Although our T2B programming is purposeful and tailored to biopharma communicators, we know it's almost impossible to attend and read everything we put out for the community. Instead, we hope that a subset of what we offer really resonates with you and serves where you're at -- wherever that is. Tomorrow, I'm holding a short, 30-minute info session to walk through the different kinds of membership and how to maximize your experience. T2B Info Session Tuesday, August 25th (tomorrow)12:30-1...